Detailed Information
Cited 0 time in 
Cited 4 time in 
Cited 4 time in
Metadata Downloads
Evaluating the recent developments in palliative chemotherapy for metastatic colorectal canceropen access
- Issue Date
- Nov-2019
- Publisher
- 대한내과학회
- Keywords
- Palliative; Chemothreapy; Metastatic colorectal cancer; Survival
- Citation
- The Korean Journal of Internal Medicine, v.34, no.6, pp 1188 - 1196
- Pages
- 9
- Journal Title
- The Korean Journal of Internal Medicine
- Volume
- 34
- Number
- 6
- Start Page
- 1188
- End Page
- 1196
- ISSN
- 1226-3303
2005-6648
- Abstract
- The incidence of colorectal cancer (CRC) has increased. CRC is the third most common cancer and the fourth most common cause of cancer-related deaths in Korea. Palliative chemotherapy can be used to shrink tumors and ease symptoms caused by the cancer when cure is not possible. It is important to identify chemotherapeutic agents that can be used to effectively treat metastatic CRC (mCRC) and thus improve the survival and quality of life of patients with mCRC. This review aimed to evaluate the recent developments in palliative chemotherapy for mCRC and the biological or targeted agents used based on genetic alterations.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Lee, Kyu Taek
- College of Medicine (Department of Internal Medicine)